Mumbai, Aug. 28 -- Aurobindo Pharma announced that United States Food and Drug Administration (US FDA) inspected Unit-VI, an API manufacturing facility of Apitoria Pharma, a wholly owned subsidiary of the Company, situated at E-Bonangi Village, Parawada Mandal, Anakapalli District, 531019, Andhra Pradesh from 24 August to 28 August 2026. The inspection concluded with three observations, which are procedural in

nature.

Published by HT Digital Content Services with permission from Capital Market....